You've Tried Everything — Here's Why Bioindividual Medicine Might Finally Work
You’ve been in therapy. You’ve tried one antidepressant, then another. A mood stabilizer. A stimulant. Maybe a benzodiazepine for the anxiety. You’ve been told to exercise more, meditate, sleep better, eat better. You’ve done some of all of that. And yet here you are — still struggling, still not right, still managing rather than thriving.
If this describes you, you’re not alone. And more importantly: the fact that conventional treatments haven’t worked is not evidence that you can’t get better. It may be evidence that the right biological question hasn’t been asked yet.
Bioindividual medicine is built on a simple premise: that every person’s biology is unique, that the factors driving mental health symptoms vary from person to person, and that treatment — to be genuinely effective — must be built around what is actually happening in *your* specific biochemistry, not around what works for the average patient in a clinical trial.
Why "Trying Everything" Doesn't Mean Running Out of Options
When patients describe having tried everything, they typically mean: everything within the conventional psychiatric toolkit. Multiple medications across different classes. Various types of psychotherapy. Lifestyle modifications. Sometimes TMS or ketamine.
These are legitimate treatments with real evidence bases. But they share a common framework: they address symptoms from the outside in, targeting neurotransmitter systems, behavioral patterns, or direct neurological stimulation.
What most of them don’t do is investigate what is happening at the biochemical level that is causing those neurotransmitter systems to malfunction in the first place.
To use a plumbing analogy: if there is a slow leak in a pipe, you can keep mopping the floor indefinitely. The mopping does something — the floor stays drier than if you didn’t mop. But you haven’t fixed the leak. And if you’re mopping with different mops without finding the leak, you’ve tried everything that mops can offer, without addressing the underlying problem.
Bioindividual medicine looks for the leak.
What Makes Someone Treatment-Resistant
Not everyone who doesn’t respond to standard psychiatric treatment has an underlying biochemical cause. But a meaningful proportion of people who cycle through medications without durable benefit do have identifiable, treatable biological factors:
Pyrrole disorder. Patients with elevated kryptopyrroles have a chronic metabolic drain on zinc and B6 — the nutrients their brain needs to produce serotonin, GABA, and dopamine. No antidepressant can compensate for this at the level of production. SSRIs extend the life of available serotonin at the synapse; they don’t generate new serotonin when the synthesis pathway is depleted.
Undermethylation. Undermethylated patients have high neurotransmitter reuptake activity. This creates a functional deficit in serotonin and dopamine signaling even if production is adequate. The treatment isn’t more serotonin reuptake inhibition — it’s restoring methyl group availability through targeted nutritional support.
Copper toxicity. Elevated free copper drives a specific pattern of anxiety, flat depression, and emotional volatility. It is biologically and pharmacologically distinct from the conditions that SSRIs are most effective for. A patient with copper-driven depression treated with an SSRI may experience partial improvement at best — the antidepressant isn’t addressing the catecholamine dysregulation that copper excess produces.
Thyroid dysfunction beyond TSH. Many treatment-resistant depression patients have low-normal free T3 or subclinical Hashimoto’s. Antidepressants don’t address thyroid function. When thyroid is optimized, some patients experience resolution of what appeared to be psychiatric depression.
Unaddressed gut dysbiosis and neuroinflammation. Gut-driven inflammation produces depression through pathways that serotonin-targeted medications don’t address. Patients with inflammatory depression — identifiable by elevated CRP, altered tryptophan metabolism, and gut dysbiosis findings — often require gut restoration to experience durable antidepressant effects.
The Difference That Individualization Makes
Here is a concrete example of why bioindividual assessment changes outcomes.
Two patients present with identical DSM diagnoses: major depressive disorder, recurrent, with anxious distress. Both have tried two SSRIs without adequate response.
Patient A has severe undermethylation, elevated whole blood histamine, high dopamine reuptake activity. The right intervention: SAMe supplementation, methionine support, zinc, and careful folate avoidance. SSRIs likely worsened their already-too-high reuptake problem. Their depression resolves with methyl donors in a way it never did with SSRIs.
Patient B has pyrrole disorder, copper toxicity, and gut dysbiosis. Their neurotransmitter production is impaired by zinc/B6 depletion, their catecholamine system is overstimulated by copper, and their gut is producing systemic inflammation. The right intervention: zinc and B6 to address pyrroles, copper reduction protocol, gut restoration, anti-inflammatory support. This patient may also benefit from medication as a bridge, but the medication alone — without addressing the underlying biochemistry — will continue to produce partial responses.
Neither patient responded to SSRIs because SSRIs don’t address the specific biological mechanism driving their depression. The treatment-resistance was a function of the wrong tool, not an inherently resistant condition.
What the Evaluation Process Looks Like
Bioindividual medicine begins with a comprehensive assessment that is unlike anything in standard psychiatric practice:
Detailed intake history. A thorough review of symptoms from childhood, family psychiatric history, developmental history, medication responses (and adverse reactions), dietary patterns, environmental exposures, hormonal history, gut symptoms, and patterns that provide clues about underlying biochemical subtypes.
Comprehensive functional lab panel. Testing that goes far beyond standard psychiatry, including methylation markers, mineral balance, pyrrole testing, gut analysis, inflammatory markers, thyroid panel, adrenal function, and more.
Pattern recognition across systems. Identifying how the lab findings, clinical history, and symptom patterns fit together into a coherent biochemical picture — not treating each result in isolation, but understanding how the various imbalances interact and compound each other.
Individualized protocol development. A targeted treatment plan built specifically around the identified imbalances — not a generic protocol, but a plan designed for one patient.
Ongoing monitoring and refinement. Labs are repeated, protocols are adjusted, and progress is tracked with objective markers as the biochemistry changes.
What "Finally Working" Looks Like
People who respond to bioindividual treatment after years of trying conventional approaches often describe the experience in similar terms:
“It’s the first time I’ve felt like myself in years.”
“I didn’t know I could feel this way. I thought my baseline was just bad.”
“The anxiety is gone. Not managed — gone. For the first time since I was a kid.”
These reports reflect what happens when the right biochemical lever is moved. When the underlying deficit is corrected — when the brain finally has the zinc it needs, the methylation capacity it needs, the copper levels it needs — the nervous system stops fighting against its own chemistry.
It doesn’t work this dramatically for everyone. Progress is often gradual. Some patients improve significantly but still require other forms of support. But the number of people for whom targeted biochemical treatment produces changes that years of conventional treatment couldn’t achieve is substantial.
You Haven't Run Out of Options
If you’ve tried everything that conventional psychiatry offers and you’re still struggling, it’s understandable to feel hopeless. But “everything conventional psychiatry offers” and “everything” are not the same thing.
There is a body of evidence-based, clinically grounded work in nutritional biochemistry and orthomolecular medicine that conventional training rarely incorporates. There are practitioners who specialize in identifying and addressing the specific biological factors that conventional treatment misses. There are patients — many of them — who have been where you are and found resolution through this approach when nothing else worked.
You haven’t tried everything. You may not have tried the right thing yet.
If the standard approaches haven’t given you your life back, bioindividual medicine may be the answer.
At MN Mensah Medical, we specialize in the complex cases — the patients who have done the work, tried the treatments, and still haven’t found lasting resolution. Our comprehensive biochemical evaluation identifies what others have missed.
Schedule a consultation to find out if bioindividual medicine is the approach that will finally work for you.